Bispecific Antibodies

Kontermann, Roland E. (EDT)

Editore: Springer Verlag, 2011
ISBN 10: 3642209092 / ISBN 13: 9783642209093
Usato / Hardcover / Quantità: 0
Copie del libro da altre librerie
Mostra tutte le  copie di questo libro

Libro

Purtroppo questa copia non è più disponibile. Di seguito ti proponiamo una lista di copie simili.

Descrizione:

Our orders are sent from our warehouse locally or directly from our international distributors to allow us to offer you the best possible price and delivery time. Codice inventario libreria

Su questo libro:

Book ratings provided by Goodreads):
0 valutazione media
(0 valutazioni)

Riassunto: The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed.

Contenuti:

Janice M. Reichert: Foreword.- Roland Kontermann: Bispecific antibodies: developments and current perspectives.- Gerd Moldenhauer: Bispecific antibodies from hybrid hybridoma.- Diego Ellerman & Justin Scheer: Generation of bispecific antibodies by chemical conjugation.- Christoph Stein, Ingo Schubert & Georg Fey: Trivalent and trispecific antibody derivatives for cancer therapy.- Dafne Müller & Roland Kontermann: Diabodies, single-chain diabodies and their derivatives.- Patrick Chames & Daniel Baty: Bispecific single domain antibodies.- John Löfblom & Fredrik Y. Frejd: Alternative scaffolds as bispecific antibody mimetics.- Nico Mertens: Tribodies: building trispecificity by Fab-scFv fusions.- Pei Jin & Zhenping Zhu: The design and engineering of IgG-like bispecific antibodies.- Edit Tarcsa, Wolfgang Fraunhofer, Tariq Ghayur, Jochen Salfeld & Jijie Gu: Dual-variable-domain immunoglobulin (DVD-IgTM) technology: a versatile, novel format for the next generation of dual-targeting biologics.- Patrick Koenig & Germaine Fuh: Two-in-one antibodies.- Chien-Hsing Chang, Edmund A. Rossi, Robert Sharkey & David M. Goldenberg: The Dock-and-Lock (DNL) approach to novel bispecifc antibodies.- Christian Kellner, Matthias Peipp & Thomas Valerius: Effector cell recruitment by bispecific antibodies.- Lawrence Lum & Archana Thakur: Bispecific anibodies for arming activated T cells and other effector cells for tumor therapy.- Patrick Baeuerle, Gerhard Zugmaier & Dominik Rüttinger: Bispecific T cell engager for cancer therapy.- Horst Lindhofer, Jürgen Hess & Peter Ruf: Trifunctional Triomab® antibodies for cancer therapy.- Bruno Robert, Christel Larbouret, David Azria, Jean-Pierre Mach & André Pèlegrin: Bispecific antibodies for the retargeting of cytokines.- Dirk Nettelbeck: Bispecific antibodies and gene therapy.- Archana Parashar, Susmita Sarkar, Advaita Ganguly, Saikiran Sharma & Mavanur R. Suresh: Bispecific antibodies for diagnostic applications.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Dati bibliografici

Titolo: Bispecific Antibodies
Casa editrice: Springer Verlag
Data di pubblicazione: 2011
Legatura: Hardcover
Condizione libro: New
Edizione: 1.

I migliori risultati di ricerca su AbeBooks

1.

Editor-Roland E. Kontermann
Editore: Springer (2011)
ISBN 10: 3642209092 ISBN 13: 9783642209093
Antico o usato Rilegato Quantità: 1
Da
Ergodebooks
(RICHMOND, TX, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer, 2011. Hardcover. Condizione: Used: Good. Codice articolo SONG3642209092

Informazioni sul venditore | Contattare il venditore

Compra usato
EUR 148,83
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,07
In U.S.A.
Destinazione, tempi e costi

2.

Editore: Springer (2011)
ISBN 10: 3642209092 ISBN 13: 9783642209093
Nuovo Rilegato Quantità: 1
Da
Irish Booksellers
(Portland, ME, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer, 2011. Condizione: New. book. Codice articolo M3642209092

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 179,83
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

3.

ROLAND E. KONTERMANN
Editore: Springer (2011)
ISBN 10: 3642209092 ISBN 13: 9783642209093
Nuovo Rilegato Quantità: 1
Da
Herb Tandree Philosophy Books
(Stroud, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, 2011. Hardback. Condizione: NEW. 9783642209093 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Codice articolo HTANDREE0355618

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 180,96
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 9,10
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

4.

Kontermann, Roland E.
ISBN 10: 3642209092 ISBN 13: 9783642209093
Nuovo Quantità: 1
Da
Paperbackshop-US
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro 2011. HRD. Condizione: New. New Book. Shipped from US within 10 to 14 business days. Established seller since 2000. Codice articolo KS-9783642209093

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 182,40
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,25
In U.S.A.
Destinazione, tempi e costi

5.

Roland E. Kontermann (editor)
Editore: Springer Berlin Heidelberg 2011-07-21, Berlin (2011)
ISBN 10: 3642209092 ISBN 13: 9783642209093
Nuovo Rilegato Quantità: 10
Da
Blackwell's
(Oxford, OX, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer Berlin Heidelberg 2011-07-21, Berlin, 2011. hardback. Condizione: New. Codice articolo 9783642209093

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 187,08
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 6,84
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

6.

Kontermann, Roland E.
Editore: Springer (2016)
ISBN 10: 3642209092 ISBN 13: 9783642209093
Nuovo Paperback Quantità: 1
Print on Demand
Da
Ria Christie Collections
(Uxbridge, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, 2016. Paperback. Condizione: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Codice articolo ria9783642209093_lsuk

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 189,25
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,40
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

7.

ISBN 10: 3642209092 ISBN 13: 9783642209093
Nuovo Rilegato Quantità: 1
Da
AussieBookSeller
(SILVERWATER, NSW, Australia)
Valutazione libreria
[?]

Descrizione libro 2011. Hardcover. Condizione: New. 2011th. Hardcover. The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disapp.Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. 373 pages. 0.748. Codice articolo 9783642209093

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 195,86
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 30,15
Da: Australia a: U.S.A.
Destinazione, tempi e costi

8.

Roland E. Kontermann
Editore: Springer-Verlag Gmbh Jul 2011 (2011)
ISBN 10: 3642209092 ISBN 13: 9783642209093
Nuovo Quantità: 1
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Jul 2011, 2011. Buch. Condizione: Neu. Neuware - The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed. 373 pp. Englisch. Codice articolo 9783642209093

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 199,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 12,09
Da: Germania a: U.S.A.
Destinazione, tempi e costi

9.

Roland E. Kontermann
Editore: Springer-Verlag Gmbh Jul 2011 (2011)
ISBN 10: 3642209092 ISBN 13: 9783642209093
Nuovo Quantità: 1
Da
Rheinberg-Buch
(Bergisch Gladbach, Germania)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Jul 2011, 2011. Buch. Condizione: Neu. Neuware - The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed. 373 pp. Englisch. Codice articolo 9783642209093

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 199,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 17,25
Da: Germania a: U.S.A.
Destinazione, tempi e costi

10.

Roland E. Kontermann
Editore: Springer-Verlag Gmbh Jul 2011 (2011)
ISBN 10: 3642209092 ISBN 13: 9783642209093
Nuovo Quantità: 1
Da
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Germania)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Jul 2011, 2011. Buch. Condizione: Neu. Neuware - The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed. 373 pp. Englisch. Codice articolo 9783642209093

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 199,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 17,25
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Vedi altre 8 copie di questo libro

Vedi tutti i risultati per questo libro